AZN
$68.94
Revenue | $11416Mn |
Net Profits | $1818Mn |
Net Profit Margins | 15.93% |
Astrazeneca Plc’s revenue jumped 5.99% since last year same period to $11416Mn in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated 4.94% jump in its revenue since last 3-months.
Astrazeneca Plc’s net profit jumped 405% since last year same period to $1818Mn in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated 0.83% jump in its net profits since last 3-months.
Astrazeneca Plc’s net profit margin jumped 376.47% since last year same period to 15.93% in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated -3.91% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.9 |
EPS Estimate Current Year | 0.9 |
Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 0.9 - a 4.75% jump from last quarter’s estimates.
Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 0.9.
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.47 |
Astrazeneca Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Astrazeneca Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Astrazeneca Plc declared 0.47 dividend per share during the earnings announcement for Q3 2023.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-09 | 0.9 | 0 | -100% |
2023-03-31 | 0.88 | 0 | -100% |
2023-06-30 | 0.86 | 0 | -100% |